Page last updated: 2024-08-23

brimonidine tartrate and Dermatitis

brimonidine tartrate has been researched along with Dermatitis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Hong, JY; Kim, BJ; Kim, MN; Lee, HW; Park, KY	1
Bertino, B; Blanchet-Réthoré, S; Bogouch, A; Bourdès, V; Dugaret, AS; Gamboa, B; Méhul, B; Nonne, C; Petit, L; Piwnica, D; Reynier, P; Roquet, M; Thibaut de Ménonville, S; Vial, E; Voegel, JJ; Zugaj, D	1
Cline, A; Feldman, SR; Okwundu, N	1
Fowler, JF	1

Reviews

1 review(s) available for brimonidine tartrate and Dermatitis

Article	Year
Difference in vasoconstrictors: oxymetazoline vs. brimonidine. The Journal of dermatological treatment, 2021, Volume: 32, Issue:2 Topics: Administration, Topical; Brimonidine Tartrate; Clinical Trials as Topic; Dermatitis; Erythema; Humans; Oxymetazoline; Rosacea; Treatment Outcome; Vasoconstrictor Agents	2021

Trials

1 trial(s) available for brimonidine tartrate and Dermatitis

Article	Year
Brimonidine displays anti-inflammatory properties in the skin through the modulation of the vascular barrier function. Experimental dermatology, 2018, Volume: 27, Issue:12 Topics: Administration, Cutaneous; Adolescent; Adult; Animals; Anti-Inflammatory Agents; Brimonidine Tartrate; Cell Movement; Dermatitis; Endothelial Cells; Erythema; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice; Middle Aged; Neutrophils; Proteome; Rosacea; Skin; Ultraviolet Rays; Vasodilation; Young Adult	2018

Article

Year

Brimonidine displays anti-inflammatory properties in the skin through the modulation of the vascular barrier function.

Experimental dermatology, 2018, Volume: 27, Issue:12

Topics: Administration, Cutaneous; Adolescent; Adult; Animals; Anti-Inflammatory Agents; Brimonidine Tartrate; Cell Movement; Dermatitis; Endothelial Cells; Erythema; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice; Middle Aged; Neutrophils; Proteome; Rosacea; Skin; Ultraviolet Rays; Vasodilation; Young Adult

2018

Other Studies

2 other study(ies) available for brimonidine tartrate and Dermatitis

Article	Year
Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy-related postinflammatory hyperpigmentation. Dermatologic therapy, 2018, Volume: 31, Issue:5 Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Anti-Inflammatory Agents; Brimonidine Tartrate; Dermatitis; Gels; Humans; Hyperpigmentation; Lasers, Solid-State; Lentigo; Male; Methylprednisolone; Middle Aged	2018
Facial Dermatitis and Rosacea. Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:6 Suppl Topics: Adrenal Cortex Hormones; Adrenergic alpha-2 Receptor Agonists; Antimicrobial Cationic Peptides; Antiparasitic Agents; Brimonidine Tartrate; Cathelicidins; Dermatitis; Dermatologic Agents; Dicarboxylic Acids; Facial Dermatoses; Humans; Ivermectin; Rosacea	2016

Article

Year

Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy-related postinflammatory hyperpigmentation.

Dermatologic therapy, 2018, Volume: 31, Issue:5

Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Anti-Inflammatory Agents; Brimonidine Tartrate; Dermatitis; Gels; Humans; Hyperpigmentation; Lasers, Solid-State; Lentigo; Male; Methylprednisolone; Middle Aged

2018

Facial Dermatitis and Rosacea.

Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:6 Suppl

Topics: Adrenal Cortex Hormones; Adrenergic alpha-2 Receptor Agonists; Antimicrobial Cationic Peptides; Antiparasitic Agents; Brimonidine Tartrate; Cathelicidins; Dermatitis; Dermatologic Agents; Dicarboxylic Acids; Facial Dermatoses; Humans; Ivermectin; Rosacea

2016